Wei-Cheng Wu
Overview
Explore the profile of Wei-Cheng Wu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
129
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Wang J, Yu Y, Zhang Z, Wu W, Sun P, Cai M, et al.
Front Bioeng Biotechnol
. 2022 Oct;
10:986033.
PMID: 36185450
Starch nanoparticles (SNPs) were produced from sweet potato starches by ultrasonic treatment combined with rapid nanoprecipitation. The starch concentration, ultrasonic time, and the ratio of starch solution to ethanol were...
2.
Zou X, Xu M, Dong X, Ying Y, Guan R, Wu W, et al.
J Food Biochem
. 2022 Apr;
46(8):e14208.
PMID: 35467031
Antrodia camphorata (A. camphorata) is an edible fungus containing various bioactive compounds generally used for health benefits. This study aimed to explore the potential neuroprotective activities of solid-state-cultured mycelium of...
3.
Chu H, Yang C, Yeh P, Hsu C, Chang L, Chan W, et al.
Cells
. 2021 Jun;
10(5).
PMID: 34068719
Circulation tumor cells (CTCs) play an important role in metastasis and highly correlate with cancer progression; thus, CTCs could be considered as a powerful diagnosis tool. Our previous studies showed...
4.
Liu Y, HuangFu W, Huang H, Wu W, Chen Y, Yen Y, et al.
Eur J Med Chem
. 2020 Jul;
202:112633.
PMID: 32688164
No abstract available.
5.
Wu W, Liu Y, Liao Y, Hsu K, Lien S, Chen I, et al.
Eur J Med Chem
. 2020 Jul;
203:112540.
PMID: 32683166
A major cause of failure of therapy in patients with non-small cell lung cancer (NSCLC) is development of acquired drug resistance leading to tumor recurrence and disease progression. In addition...
6.
Wu W, Wang S, Ou S, Liu Y, Liu B, Tseng F
Nanomedicine (Lond)
. 2020 Apr;
15(11):1067-1077.
PMID: 32326875
To improve the killing efficacy of head and neck squamous cells (SAS) by boric acid-mediated boron neutron capture therapy (BNCT). Boric acid-containing chitosan/alginate/polyvinyl alcohol nanoparticles (B-capNPs) were manufactured using the...
7.
Wu W, Liu Y, Lin M, Liao Y, Lai M, Chuang H, et al.
Eur J Med Chem
. 2020 Apr;
196:112329.
PMID: 32311605
No abstract available.
8.
Li C, Ou C, Huang C, Wu W, Chen Y, Lin T, et al.
J Mater Chem B
. 2020 Apr;
2(28):4564-4571.
PMID: 32261557
Fluorescent carbon nanodots (C-dots; 4.3 ± 0.8 nm) from fresh tender ginger juice provide high suppression of the growth of human hepatocellular carcinoma cells (HepG2), with low toxicity to normal...
9.
Wu W, Liu Y, Lin M, Liao Y, Lai M, Chuang H, et al.
Eur J Med Chem
. 2020 Mar;
192:112158.
PMID: 32171161
Microtubule-targeting agents (MTA) have enjoyed significant clinical success for decades. However, several mechanisms may cause inactivation of such drugs, leading to acquired resistance in patients treated with them. Therefore, drugs...
10.
Wu W, Chen H, Lin S, Chen H, Chen F, Chang H, et al.
Mikrochim Acta
. 2019 Feb;
186(3):166.
PMID: 30739206
Stable and low-cost carbon dots (C-dots) were prepared from polyethylenimine (PEI) by a hydrothermal method. It is found that the fluorescence of the C-dots (best measured at excitation/emission wavelengths of...